Allostery Exploration Technologies (ALLOX) is developing a platform to map allosteric sites in disease-relevant proteins and design selective medicines targeting them
Allostery Exploration Technologies (ALLOX) is developing a platform to map allosteric sites in disease-relevant proteins and design selective medicines targeting them. Its multidimensional mutagenesis method measures up to one million protein variants per experiment, linking genetic changes to phenotypic and biophysical outcomes. The platform is currently focused on oncology, with potential applications across other diseases.